Coegin Pharma AS (NGM:COEGIN) agreed to acquire Follicum AB (publ) for SEK 35.4 million on September 22, 2021. As per the transaction, Coegin Pharma AS will issue one share for each share of Follicum AB (publ). Accordingly, Coegin Pharma AS will issue 81.698 million shares as consideration. Post completion, Follicum AB will be merged. The merger will be approved by an Extraordinary General Meeting in Follicum during the beginning of November and is expected to be completed and registered in the first quarter of 2022.

Coegin Pharma AS (NGM:COEGIN) completed the acquisition of Follicum AB (publ) on February 7, 2022. Post completion, it has been merged.